carbamates has been researched along with Fatty Liver, Nonalcoholic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, HM | 1 |
| Fan, SJ | 1 |
| Zhou, XR | 1 |
| Liu, YJ | 1 |
| Li, X | 1 |
| Liao, LP | 1 |
| Huang, J | 1 |
| Shi, CC | 1 |
| Yu, L | 1 |
| Fu, R | 1 |
| Fan, JG | 1 |
| Zhang, YY | 1 |
| Luo, C | 1 |
| Li, GM | 1 |
1 other study available for carbamates and Fatty Liver, Nonalcoholic
| Article | Year |
|---|---|
Histone deacetylase inhibitor givinostat attenuates nonalcoholic steatohepatitis and liver fibrosis.
Topics: Animals; Carbamates; Histone Deacetylase Inhibitors; Liver; Liver Cirrhosis; Methionine; Mice; Mice, | 2022 |